Two Voyager directors request not to be renominated; search for replacements underway

Voyager Therapeutics, Inc.

Mark Levin and Steven Paul, M.D. will not stand for re-election at 2022 annual meeting.
Both directors cited desire to reduce professional commitments and board seats.
Departures not due to any disagreement with board or management.
Nominating committee has engaged search firm to fill anticipated vacancies.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Steven Paul, M.D.

Director

VYGR · Voyager Therapeutics, Inc.

Filed: April 20, 2022, 7:59 PM ET

Mark Levin and Steven Paul, M.D. each requested not to be nominated for re-election to the Board when his current term expires at the Company’s 2022 annual meeting of stockholders.

Departed

Mark Levin

Director

VYGR · Voyager Therapeutics, Inc.

Filed: April 20, 2022, 7:59 PM ET

Mark Levin and Steven Paul, M.D. each requested not to be nominated for re-election to the Board when his current term expires at the Company’s 2022 annual meeting of stockholders.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Steven Paul, M.D. departed as Director at Voyager Therapeutics, Inc..

Action: requested not to be nominated
Role: Director

Exact text from the filing

Mark Levin and Steven Paul, M.D. each requested not to be nominated for re-election to the Board when his current term expires at the Company’s 2022 annual meeting of stockholders.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Mark Levin departed as Director at Voyager Therapeutics, Inc..

Action: requested not to be nominated
Role: Director

Exact text from the filing

Mark Levin and Steven Paul, M.D. each requested not to be nominated for re-election to the Board when his current term expires at the Company’s 2022 annual meeting of stockholders.

View on SEC.gov

Voyager Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-22-047904

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.